Current TGA Registered Products

Omegapharm Irinotecan
Omegapharm Nystatin Oral Solution

Omegapharm Acetylcysteine Inhalation/ Oral Solution
Omegapharm Cefepime

Omegapharm’s product range was developed in consultation with Australian hospital pharmacists. The range has been tailored to meet the diverse medical needs of patients in an innovative, socially responsible and commercially viable manner.

Omegapharm has acquired the rights to a number of high quality established sterile injectable products. These medicines cover a broad range of disease areas incorporating; infectious diseases, oncology, pain management and dermatology.

Omegapharm’s innovative partnership with our manufacturing partners provides a foundation for us to commercialize generic products based on the needs of Australian hospital pharmacies.

Our manufacturing agreements advance our goal to provide hospital pharmacies with a wide offering of affordable medicines they can trust. Omegapharm’s manufacturing partners have reputation for high quality and supply reliability in the critical area of sterile injectables.

Omegapharm’s international manufacturing partners have broad established medicine portfolios and world-class TGA GMP approved manufacturing capabilities. When you combine this with Omegapharm’s flat corporate structure, you have the unique ability to supply high-quality medicines at affordable prices to Australian hospital pharmacies.